Product ID:NORGESIC AND NORGESIC FORTE (PRESCRIPTION DRUG)
MSDS Date:08/22/1996
FSC:6505
NIIN:01-029-9116
MSDS Number: BYFBM

3M PHARMACEUTICAL, SUB OF MINNESOTA MINING AND MFG

19901 NORDHOFF ST
NORTHRIDGE, CA 91324-3213
US

Emergency Phone: 818-709-3076/612-733-1110

Info Phone: 818-709-3076/612-733-1110

Cage: 04515

MINNESOTA MINING AND MFG CO 3M PHARMACEUTICAL

NORTHRIDGE, CA 91324-3298 US

Telephone: 818-709-3076

Cage: 04515

ASPIRIN

CAS: 50-78-2

RTECS: VO0700000

Fraction By Weight: 57.0%

OSHA PEL 5 MG/M3

ACGIH TLV: 5 MG/M3; 9495

ORPHENADRINE CITRATE

CAS: 4682-36-4

RTECS: KR6125000

Fraction By Weight: 4.0%

EXCIPIENTS

Fraction By Weight: 35.0%

CAFFEINE

CAS: 58-08-2

RTECS: EV6475000

Fraction By Weight: 4.0%

LD50 LC50 Mixture:LD50 (ORAL, ANIMAL) 192-1000 MG/KG
Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:TARGET ORGANS:GASTROINTESTINAL TRACT.
ACUTE- EYE/SKIN/INHALATION:EXPOSURE NOT LIKELY DUE TO THE PHYSICAL
FORM OF THE TABLET. ORAL:MODERATE ORAL TOXICITY. IF SWALLOWED MAY
CAUSE UPSET STOMACH, PAIN, NA USEA. CHRONIC- UNKNOWN.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:NAUSEA, VOMITING

First Aid:EYE/SKIN/INHALATION:NOT RELEVANT. ORAL:CALL A PHYSICIAN.

Flash Point:NONE
Extinguishing Media:WATER, CARBON DIOXIDE, DRY CHEMICAL EXTINGUISHER,
FOAM.
Fire Fighting Procedures:WEAR PROTECTIVE CLOTHING AND NIOSH-APPROVED
SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:NONE

Spill Release Procedures:COLLECT SPILLED MATERIAL. PLACE IN AN APPROVED
METAL CONTAINER AND SEAL.
Neutralizing Agent:NOT RELEVANT

Handling and Storage Precautions:STORE IN COOL PLACE, IN ORIGINAL
CONTAINERS. KEEP OUT OF REACH OF CHILDREN.
Other Precautions:AS A GENERAL RULE, WHEN HANDLING PHARMACEUTICAL OR
LABORATORY PRODUCTS, AVOID ALL FORMS OF CONTACT AND INHALATION OF
DUST, FUMES, MISTS, AND/OR VAPORS ASSOCIATED WITH THE PRODUCT. WASH
THOROUGHLY AFTE R HANDLING AND BEFORE EATING OR DRINKING

Respiratory Protection:NONE NORMALLY REQUIRED.
Ventilation:NONE NORMALLY REQUIRED.
Protective Gloves:LATEX RECOMMENDED
Eye Protection:SAFETY GOGGLES RECOMMENDED
Other Protective Equipment:PROVIDE EYE WASH, SAFETY SHOWER AND LAB
COAT.
Work Hygienic Practices:OBSERVE GOOD PERSONAL HYGIENE PRACTICES AND
RECOMMENDED PROCEDURES.
Supplemental Safety and Health
THIS PRODUCT IS APPROVED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION
(FDA) FOR USE AS A PRESCRIPTION DRUG. PRESCRIPTION DRUGS MUST BE
CONTROLLED BY CONTRACT, THAT IS, REQUIRED SIGNING FOR/ACCOUNTING F
OR DELIVERY AND RECEIVING AND CONTROL DURING STORAGE.

HCC:N1
Melt/Freeze Pt:M.P/F.P Text:NOT KNOWN
Decomp Temp:Decomp Text:NOT KNOWN
Viscosity:NOT RELEVANT
Evaporation Rate & Reference:NOT RELEVANT
Appearance and Odor:YELLOW/GREEN/WHITE TABLET

Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:EXCESSIVE HEAT
Hazardous Decomposition Products:CARBON MONOXIDE, CARBON DIOXIDE
Conditions to Avoid Polymerization:WILL NOT OCCUR.

Waste Disposal Methods:MIX WITH FLAMMABLE MATERIAL AND INCINERATE IN AN
INDUSTRIAL OR COMMERCIAL FACILITY IN ACCORDANCE WITH ALL LOCAL,
STATE AND FEDERAL REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.